Article: Key Cardiology Research Presented In Stockholm: New ER-TIMI 19 Study Reports That Pre-Hospital Administration of RETAVASE(R) May Save Time to Treatment For Heart-Attack Patients.

Article: Study Shows Pre-Hospital Administration of RETAVASE(R) Can ...
PR Newswire;  July 2, 2002 ;     700+ words ... ... in treating heart attacks." He added that RETAVASE is the leader ... first bolus of RETAVASE. Fourteen ... Americans suffer heart attacks each year ... deaths from heart attacks each year occur ... breath. About RETAVASE RETAVASE is ...

Article: Lancet Study Reports Results of Combining RETAVASE and ...
Business Wire;  June 14, 2001 ;     700+ words ... ... year. Approximately 450,000 of these heart attacks are recurrent heart attacks. Nearly all heart attacks are caused by a thrombus -- a blood clot ... busting, or thrombolytic, agents such as RETAVASE target only the fibrin component of clots ...

Article: Biovail to Market Centocor's Retavase in Canada; Product ...
Business Wire;  September 15, 1998 ;     700+ words ... ... reteplase) in Canada. Retavase, a fibrinolytic ... patients suffering from heart attacks each year. Retavase, a biotechnology ... patients who suffer from heart attacks. Widespread research ... affected artery. Retavase is the only fibrinolytic ...

Article: Additional GUSTO III data confirm efficacy and safety of new ...
Business Wire;  May 19, 1997 ;     700+ words ... ... country have already begun using Retavase," said Anthony Yost, vice ... with further confidence in Retavase's ability to save, and ... their patients who suffer from heart attacks." The GUSTO III study was ... randomized to receive either Retavase, administered as two intravenous ...

Article: Centocor Reports 1998 First Quarter Results; Quarter Includes ...
PR Newswire;  April 20, 1998 ;     700+ words ... ... connection with the acquisition of Retavase(TM) (reteplase ... days in reducing death and heart attacks. -- Also at the ACC meeting ... the GP IIb/IIIa receptor. Retavase(TM) (reteplase) -- On ... Canadian product rights for Retavase from Roche Healthcare Limited ...

Article: New Study Shows RETAVASE(R) Provides Superior Benefits In ...
PR Newswire;  August 2, 1999 ;     700+ words ... ... PRNewswire/ -- The "clot-buster" RETAVASE(R) (reteplase recombinant) demonstrated ... the American Heart Journal, compared RETAVASE to the standard clot-busting treatment ... Centocor, Inc. (Nasdaq: CNTO) markets RETAVASE in the United States. PE, which is ...

Article: New Data Show Combination of Centocor's ReoPro(R) and Low-Dose ...
PR Newswire;  August 30, 1999 ;     700+ words ... ... with a reduced dose of the clot-buster RETAVASE(R) (reteplase) restores optimal ... attack patients, compared with using RETAVASE alone. These results, presented here ... initiation of ReoPro and differing doses of RETAVASE, given 30 minutes apart, ReoPro alone ...